Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells
Stem Cells · 01.08.2024 · 42 (8) · 736-751
DOI: 10.1093/stmcls/sxae040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, online erschienen am 03.06.2024. Verfasst von Tyler U Faircloth und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31324, United States. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Mercer University School of Medicine's Research funds, Mercer University School of Medicine’s Research funds.
Abstract (Originalsprache)
Mesenchymal stromal cells (MSCs) are investigated as cellular therapeutics for inflammatory bowel diseases and associated perianal fistula, although consistent efficacy remains a concern. Determining host factors that modulate MSCs’ potency including their secretion of angiogenic and wound-healing factors, immunosuppression, and anti-inflammatory properties are important determinants of their functionality. We investigated the mechanisms that regulate the secretion of angiogenic and wound-healing factors and immune suppression of human bone marrow MSCs. Secretory analysis of MSCs focusing on 18 angiogenic and wound-healing secretory molecules identified the most abundancy of vascular endothelial growth factor A (VEGF-A). MSC viability and secretion of other angiogenic factors are not dependent on VEGF-A secretion which exclude the autocrine role of VEGF-A on MSC’s fitness. However, the combination of inflammatory cytokines IFNγ and TNFα reduces MSC’s VEGF-A secretion. To identify the effect of intestinal microvasculature on MSCs’ potency, coculture analysis was performed between human large intestine microvascular endothelial cells (HLMVECs) and human bone marrow-derived MSCs. HLMVECs do not attenuate MSCs’ viability despite blocking their VEGF-A secretion. In addition, HLMVECs neither attenuate MSC’s IFNγ mediated upregulation of immunosuppressive enzyme indoleamine 2,3-dioxygenase nor abrogate suppression of T-cell proliferation despite the attenuation of VEGF-A secretion. We found that HLMVECs express copious amounts of endothelial nitric oxide synthase and mechanistic analysis showed that pharmacological blocking reverses HLMVEC-mediated attenuation of MSC’s VEGF-A secretion. Together these results suggest that secretion of VEGF-A and immunosuppression are separable functions of MSCs which are regulated by distinct mechanisms in the host.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31324, United States.
- Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, United States.
- Division of Pediatric Gastroenterology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
ORCID-Profile: Subra Kugathasan, Raghavan Chinnadurai
Förderung
- Mercer University School of Medicine's Research funds
- Mercer University School of Medicine’s Research funds
Zitieren
APA
Faircloth, T. U., Temple, S., Parr, R. N., Tucker, A. B., Rajan, D., Hematti, P., Kugathasan, S., & Chinnadurai, R. (2024). Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells. Stem Cells, 42(8), 736-751. https://doi.org/10.1093/stmcls/sxae040
Vancouver
Faircloth TU, Temple S, Parr RN, Tucker AB, Rajan D, Hematti P, et al. Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells. Stem Cells. 2024;42(8):736-751. doi:10.1093/stmcls/sxae040
BibTeX
@article{Faircloth2024,
author = {Faircloth, Tyler U and Temple, Sara and Parr, Rhett N and Tucker, Anna B and Rajan, Devi and Hematti, Peiman and Kugathasan, Subra and Chinnadurai, Raghavan},
title = {Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells},
journal = {Stem Cells},
year = {2024},
volume = {42},
number = {8},
pages = {736--751},
doi = {10.1093/stmcls/sxae040}
}
EUVIMED